Kennedy admits that he personally ordered CDC to update website on vaccines and autism, contradicting many years of guidance

Health Secretary Robert F. Kennedy Jr. personally ordered the CDC to rewrite its vaccine-safety web page to cast doubt on the long-standing assertion that vaccines do not cause autism, a surprise move to many agency staff that public-health experts immediately and strongly disputed as misleading given decades of research finding no link. The revised CDC text suggests the “vaccines do not cause autism” statement isn’t supported by evidence and implies studies showing potential links were ignored; Kennedy acknowledged studies disproving links from thimerosal and MMR but said gaps remain, while critics including Sen. Bill Cassidy and major medical groups warned the change undermines trust. The action follows broader moves by Kennedy—pulling $500 million for vaccine development, replacing the federal vaccine advisory committee, and ousting CDC leadership—which together raise political and policy uncertainty for immunization programs, vaccine development and public-health credibility.

Analysis

Health Secretary Robert F. Kennedy Jr. personally ordered the CDC to revise its vaccine-safety webpage to cast doubt on the long-standing statement that "vaccines do not cause autism," telling The New York Times he left gaps in vaccine-safety science despite acknowledging studies that found no link for thimerosal and MMR. The revised CDC text and a disclaimer reflecting Kennedy’s agreement with Sen. Bill Cassidy surprised many agency staff and prompted immediate, forceful rebuttals from public-health researchers and groups such as the Autism Science Foundation and the American Academy of Pediatrics, who say decades of rigorous research show no causal link.

Kennedy’s website change follows broader actions he has taken as health secretary: rescinding $500 million for vaccine development, replacing the federal vaccine advisory committee, pledging an overhaul of the vaccine-injury compensation program, and ousting CDC leadership. These concentrated policy moves create tangible regulatory and funding uncertainty for federal immunization programs and vaccine-development activities and have generated a strongly negative sentiment signal (sentiment_score -0.7) with particularly negative per-ticker sentiment for the CDC (-0.8).

Key near-term risks are erosion of public trust in government health guidance, potential impacts on vaccine uptake as warned by medical leaders, and heightened legislative and reputational scrutiny led by Senate figures such as Cassidy; investors should monitor HHS/CDC communications, congressional responses, and funding flows as primary indicators of policy direction.

Key Decisions for Investors

• Reassess exposure to firms and contractors reliant on federal vaccine-development funding given the reported $500 million rescission and heightened policy uncertainty
• Monitor HHS and CDC statements, congressional hearings (Sen. Bill Cassidy) and any reversals of website guidance as immediate catalysts for volatility in healthcare and public-health-related equities
• Consider hedging or reducing concentration in names closely tied to federal immunization programs until funding and advisory-board stability are clarified
• Track public-health sentiment and uptake metrics reported by major medical groups because sustained erosion of trust, as signaled by expert pushback, could alter demand dynamics for vaccines and related services